Anti-ANT3/ ATIII/ SERPINC1 monoclonal antibody
Anti-ANT3/ ATIII/ SERPINC1 antibody for FACS & in-vivo assay
Go to ATIII/SERPINC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T73476-Ab-1/ GM-Tg-hg-T73476-Ab-2 | Anti-Human ATIII/SERPINC1 monoclonal antibody | Human |
GM-Tg-rg-T73476-Ab-1/ GM-Tg-rg-T73476-Ab-2 | Anti-Rat ATIII/SERPINC1 monoclonal antibody | Rat |
GM-Tg-mg-T73476-Ab-1/ GM-Tg-mg-T73476-Ab-2 | Anti-Mouse ATIII/SERPINC1 monoclonal antibody | Mouse |
GM-Tg-cynog-T73476-Ab-1/ GM-Tg-cynog-T73476-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ATIII/SERPINC1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T73476-Ab-1/ GM-Tg-felg-T73476-Ab-2 | Anti-Feline ATIII/SERPINC1 monoclonal antibody | Feline |
GM-Tg-cang-T73476-Ab-1/ GM-Tg-cang-T73476-Ab-2 | Anti-Canine ATIII/SERPINC1 monoclonal antibody | Canine |
GM-Tg-bovg-T73476-Ab-1/ GM-Tg-bovg-T73476-Ab-2 | Anti-Bovine ATIII/SERPINC1 monoclonal antibody | Bovine |
GM-Tg-equg-T73476-Ab-1/ GM-Tg-equg-T73476-Ab-2 | Anti-Equine ATIII/SERPINC1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T73476-Ab-1/ GM-Tg-hg-T73476-Ab-2; GM-Tg-rg-T73476-Ab-1/ GM-Tg-rg-T73476-Ab-2; GM-Tg-mg-T73476-Ab-1/ GM-Tg-mg-T73476-Ab-2; GM-Tg-cynog-T73476-Ab-1/ GM-Tg-cynog-T73476-Ab-2; GM-Tg-felg-T73476-Ab-1/ GM-Tg-felg-T73476-Ab-2; GM-Tg-cang-T73476-Ab-1/ GM-Tg-cang-T73476-Ab-2; GM-Tg-bovg-T73476-Ab-1/ GM-Tg-bovg-T73476-Ab-2; GM-Tg-equg-T73476-Ab-1/ GM-Tg-equg-T73476-Ab-2 |
Products Name | Anti-ATIII/SERPINC1 monoclonal antibody |
Format | mab |
Target Name | ATIII |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ATIII benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species ANT3/ ATIII/ SERPINC1 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | vGMAAV000297 | human SERPINC1 AAV particle |
ORF Viral Vector | pGMAAV000297 | human SERPINC1 AAV plasmid |
ORF Viral Vector | vGMAAV000149 | human SERPINC1 AAV particle |
ORF Viral Vector | pGMLP002891 | human SERPINC1 Lentivirus plasmid |
ORF Viral Vector | vGMLP002891 | human SERPINC1 Lentivirus particle |
ORF Viral Vector | pGMAAV000149 | human SERPINC1 AAV plasmid |
ORF Viral Vector | pGMAD000029 | rat Serpinc1 Adenovirus plasmid |
ORF Viral Vector | pGMAAV000091 | mouse Serpinc1 AAV plasmid |
ORF Viral Vector | vGMAD000029 | rat Serpinc1 Adenovirus particle |
ORF Viral Vector | vGMAAV000091 | mouse Serpinc1 AAV particle |
Target information
Target ID | GM-T73476 |
Target Name | ATIII |
Gene ID | 462,11905,304917,708854,480066,101093983,540261,100061173 |
Gene Symbol and Synonyms | At-3,AT3,AT3D,ATIII,ATIII-R2,ATIII-T1,ATIII-T2,SERPINC1,THPH7 |
Uniprot Accession | P01008,P41361 |
Uniprot Entry Name | ANT3_HUMAN,ANT3_BOVIN |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000117601 |
Target Classification | N/A |
The target: ATIII, gene name: SERPINC1, also named as AT3, AT3D, ATIII, ATIII-R2, THPH7. The protein encoded by this gene, antithrombin III, is a plasma protease inhibitor and a member of the serpin superfamily. This protein inhibits thrombin as well as other activated serine proteases of the coagulation system, and it regulates the blood coagulation cascade. The protein includes two functional domains: the heparin binding-domain at the N-terminus of the mature protein, and the reactive site domain at the C-terminus. The inhibitory activity is enhanced by the presence of heparin. Numerous mutations have been identified for this gene, many of which are known to cause antithrombin-III deficiency which constitutes a strong risk factor for thrombosis. A reduction in the serum level of this protein is associated with severe cases of Coronavirus Disease 19 (COVID-19). [provided by RefSeq, Sep 2020].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.